Cytogenetic Risk Stratification in Primary Versus Post-Essential Thrombocythemia / Post-Polycythemia Vera Myelofibrosis

被引：1
|
作者：
Masarova, Lucia
Bose, Prithviraj
Daver, Naval G.
Pemmaraju, Naveen
Newberry, Kate J.
Cortes, Jorge E.
Kantarjian, Hagop M.
Verstovsek, Srdan
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.4250.4250
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4250
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Clinical Associations of Cytogenetic Abnormalities in Patients with Primary and Post-Essential Thrombocythemia and Post-Polycythemia Vera Myelofibrosis
    Masarova, Lucia
    Bose, Prithviraj
    Pemmaraju, Naveen
    Newberry, Kate J.
    Bueso-Ramos, Carlos E.
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. BLOOD, 2016, 128 (22)
  • [2] The Evolving Understanding of Prognosis in Post-Essential Thrombocythemia Myelofibrosis and Post-Polycythemia Vera Myelofibrosis vs Primary Myelofibrosis
    Masarova, Lucia
    Verstovsek, Srdan
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 299 - 307
  • [3] Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
    Mora, Barbara
    Giorgino, Toni
    Guglielmelli, Paola
    Rumi, Elisa
    Maffioli, Margherita
    Rambaldi, Alessandro
    Caramella, Marianna
    Komrokji, Rami
    Gotlib, Jason
    Kiladjian, Jean Jacques
    Cervantes, Francisco
    Devos, Timothy
    Palandri, Francesca
    De Stefano, Valerio
    Ruggeri, Marco
    Silver, Richard T.
    Benevolo, Giulia
    Albano, Francesco
    Cavalloni, Chiara
    Barraco, Daniela
    Merli, Michele
    Pietra, Daniela
    Casalone, Rosario
    Barbui, Tiziano
    Rotunno, Giada
    Cazzola, Mario
    Vannucchi, Alessandro Maria
    Passamonti, Francesco
    [J]. HAEMATOLOGICA, 2018, 103 (09) : E392 - E394
  • [4] Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis
    Masarova, Lucia
    Bose, Prithviraj
    Daver, Naval
    Pemmaraju, Naveen
    Newberry, Kate J.
    Manshouri, Taghi
    Cortes, Jorge
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. LEUKEMIA RESEARCH, 2017, 59 : 110 - 116
  • [5] A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia
    Mesa, R. A.
    Camoriano, J. K.
    Geyer, S. M.
    Wu, W.
    Kaufmann, S. H.
    Rivera, C. E.
    Erlichman, C.
    Wright, J.
    Pardanani, A.
    Lasho, T.
    Finke, C.
    Li, C. Y.
    Tefferi, A.
    [J]. LEUKEMIA, 2007, 21 (09) : 1964 - 1970
  • [6] A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia
    R A Mesa
    J K Camoriano
    S M Geyer
    W Wu
    S H Kaufmann
    C E Rivera
    C Erlichman
    J Wright
    A Pardanani
    T Lasho
    C Finke
    C Y Li
    A Tefferi
    [J]. Leukemia, 2007, 21 : 1964 - 1970
  • [7] Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
    A Tefferi
    L Saeed
    C A Hanson
    R P Ketterling
    A Pardanani
    N Gangat
    [J]. Leukemia, 2017, 31 : 2851 - 2852
  • [8] Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
    Sliwa, Thamer
    Beham-Schmid, Christine
    Burgstaller, Sonja
    Buxhofer-Ausch, Veronika
    Gastl, Guenther
    Geissler, Klaus
    Krauth, Maria
    Krippl, Peter
    Lang, Alois
    Petzer, Andreas
    Woehrer, Stefan
    Woelfler, Albert
    Gisslinger, Heinz
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (9-10) : 293 - 302
  • [9] Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
    Tefferi, A.
    Saeed, L.
    Hanson, C. A.
    Ketterling, R. P.
    Pardanani, A.
    Gangat, N.
    [J]. LEUKEMIA, 2017, 31 (12) : 2851 - 2852
  • [10] Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
    Thamer Sliwa
    Christine Beham-Schmid
    Sonja Burgstaller
    Veronika Buxhofer-Ausch
    Günther Gastl
    Klaus Geissler
    Maria Krauth
    Peter Krippl
    Alois Lang
    Andreas Petzer
    Stefan Wöhrer
    Albert Wölfler
    Heinz Gisslinger
    [J]. Wiener klinische Wochenschrift, 2017, 129 : 293 - 302
12345